Immunohistochemical and immunoblot study of GABAA α1 and β2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder

Neuroscience Research

Volumn 50, Issue 1, 2004, Pages 77-84

  Ishikawa, Masanori ^a   Mizukami, Katsuyoshi ^a   Iwakiri, Masahiko ^a   Hidaka, Shin ^a   Asada, Takashi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Bipolar disorder; GABAA receptor; Immunoblotting; Immunohistochemistry; Prefrontal cortex; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; GAMMA AMINOBUTYRATE RECEPTOR ALPHA 1; GAMMA AMINOBUTYRATE RECEPTOR BETA 2; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MALE; NEUROPIL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; BIPOLAR DISORDER; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS; NEUROPIL; PREFRONTAL CORTEX; PROTEIN SUBUNITS; RECEPTORS, GABA-A; SCHIZOPHRENIA;

EID: 3543080535     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2004.06.006     Document Type: Article

References (28)

1. A receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cerebral Cortex. 5:1991;550-560
2. American Psychiatric Association, 1997. Practical guideline for the treatment of patients with schizophrenia. Am. J. Psychiatry 154, 1-63.
3. Barch D.M., Sheline Y.I., Csernansky J.G., Snyder A.Z. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol. Psychiatry. 53:2003;376-384
4. Baumann B., Bogerts B. The pathomorphology of schizophrenia and mood disorders: similarities and differences. Schizophr. Res. 39:1999;141-148
5. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr. Res. 24:1997;349-355
6. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 25:2001;1-27
7. 65-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20:2000;259-269
8. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031
9. A/benzodiazepine binding sites and glutamic acid decarboxylase activity in suicide victims. Brain Res. 460:1988;114-123
10. A receptors in schizophrenia. J. Neurochem. 72:1999;1593-1599
11. 3H ] muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder J. Affect. Disord. 66:2001;147-158
12. A/benzodiazepine receptor. J. Cell Biol. 110:1990;2043-2048
13. Farnbach-Pralong D., Bradbury R., Copolov D., Dean B. Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors. Eur. J. Pharmacol. 349:1998;R7-R8
14. Feighner J.P., Robins E., Guze S.B. Diagnostic criteria for use in psychiatric research. Arch. Gen. Psychiatry. 126:1972;57-63
15. 3H ] muscimol binding sites increased in autopsied brains of chronic schizophrenics Life Sci. 40:1987;259-266
16. Hetmar O., Nielsen M., Braestrup C. Decreased number of benzodiazepine receptors in frontal cortex of rat brain following long-term lithium treatment. J. Neurochem. 41:1983;217-221
17. Knable M.B. Schizophrenia and bipolar disorder: findings from studies of Stanley Foundation Brain Collection. Schizophr. Res. 39:1999;149-152
18. Lewis D.A. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res. Rev. 31:2000;270-276
19. A receptor channels. Annu. Rev. Neurosci. 17:1994;569-602
20. McKernan R.M., Whiting P.J. Which GABA-receptor subtypes really occur in the brain? Trends Nurosci. 19:1996;139-143
21. A receptor β2/3 subunits in the hippocampal formation of aged brains with Alzheimer- related neuropathologic changes. Exp. Neurol. 147:1997;333-345
22. A receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res. 799:1998;148-155
23. Motohashi N. GABA receptor alterations after chronic lithium administration: comparison with carbamazepine and sodium valproate. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;571-579
24. A receptor α-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience. 93:1999;441-448
25. Petty F. GABA and mood disorders: a brief review and hypothesis. J. Affect. Disord. 34:1995;275-281
26. Reynolds G.P., Beasley C.L. GABAergic neuronal subtypes in the human frontal cortex development and deficits in schizophrenia. J. Chem. Neuroanat. 22:2001;95-100
27. Whitehouse P.J., Lynch D., Kuhar M.J. Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of human autopsy process. J. Neurochem. 43:1984;553-559
28. Zezula J., Cortes R., Probst A., Palacios J.M. Benzodiazepine receptor sites in the human brain: autoradiographic mapping. Neuroscience. 25:1988;771-795